During the projected period between 2022 and 2032, it is expected that demand for Drug Free Depression Treatment Market will grow at a moderate CAGR of between 2% and 4%. Growth is ascribed to the little or nonexistent negative effects of drug-free depression treatments, which are becoming more and more popular worldwide. During the projected …
Author Archives: Editor AM
Dual and Multi-Energy Computed Tomography (CT) Market is projected to reach US$ 2.6 Bn by 2029 at a CAGR of 802%
The global Dual and Multi-energy Computed Tomography (CT) Market is anticipated to grow from a valuation of US$ 1.5 Bn in 2022 to US$ 2.6 Bn by 2029, expanding at a high CAGR of 8.2%. Expanding patient pool suffering from cancer, cardiovascular diseases, and dental and orthopedic disorders is primarily driving the need for dual …
Medical Ventilators Market to reach US$ 3.1 Bn by the end of 2030 | Says FMI Analyst
The global Medical Ventilators Market is expected to grow at a 9.1% CAGR from US$ 1.4 billion in 2021 to US$ 3.1 billion by 2030. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Medical Ventilators market. FMI offers insights into …
MENA Syringes & Cannula Market is expected to reach US$ 2.4 Bn by 2031, with CAGR 6.4%
The MENA syringes and cannula market is expected to grow at a 6.4% CAGR during the forecast period. By 2032, the market is expected to be worth US$ 2.4 billion. In 2020, the disposable segment represented 87.3% of the total market share, a trend that is likely to continue throughout the forecast period. Increasing preference …
Metered Dose Inhalers Market is predicted to advance at a CAGR of 4.3% from 2022 to 2032.
The global Metered Dose Inhalers Market is expected to be valued at US$ 40,140 million by 2032, up from US$ 25,210 million in 2022, with a CAGR of 4.3% during the forecast period. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis …
Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market is set to expand 1.4X over the forecast years.
According to a recent market analysis conducted by Future Market Insights (FMI), the global Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market was valued at US$ 3.8 billion in 2021 and is anticipated to reach US$ 5.5 billion by 2030. Sepsis, toxic shock syndrome, bacteremia, osteomyelitis, endocarditis, meningitis, pneumonia are amongst the life-threatening diseases caused by Staphylococcus …
Microplate Washer Expanding Research and Development Projects to Drive Market Growth
The global healthcare business has undergone massive technological development, leaving key market actors having to navigate the complexity of medical and life sciences. Given the changing dynamics of the global healthcare sector, pharmaceutical and biotech firms are making concerted efforts to improve patient outcomes in an efficient manner while keeping a close eye on the …
Electronic Stethoscope Market | Eko Devices, eKuore, GlobalMed, 3M | By 2029
Global sales of Electronic Stethoscope Market are anticipated to hit US$ 259 million by 2029, growing by 2.2 times between 2022 and 2029, from a market value of US$ 170.9 million in 2021. With the rising incidence of cardiovascular illnesses and the introduction of cutting-edge technology in the healthcare industry, demand in the market is …
Continue reading “Electronic Stethoscope Market | Eko Devices, eKuore, GlobalMed, 3M | By 2029”
Non-Invasive Blood Glucose Monitoring Devices Market Research Examines Huge Future Growth
Diabetes has emerged into a primary healthcare epidemic characterized by high blood sugar levels and the leading cause of death worldwide. The World Health Organization (WHO) estimated that 8.5% of individuals had diabetes in 2014. A diabetic cannot either manufacture enough insulin (type 1 diabetes) or does not create enough insulin or does not utilise …
Oral Solid Dosage Pharmaceutical Formulation Market | AstraZeneca Plc., Bristol-Myers Squibb Company, Gilead Sciences, Merck & Co. Inc | By 2032
Demand for the global Oral Solid Dosage Pharmaceutical Formulation Market is anticipated to expand at a robust CAGR of 6.4% over the valuation period from 2022 to 2032. The global market is expected to touch US$ 555.3 Mn by 2022 and surpass a valuation of US$ 1.0 Bn in 2032. As per the studies, on the …